Jeffrey Luebbert, MD
Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1295917664
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $10,518 and has fallen 72.7% since, to $2,876 in 2025.
Across 225 payments — averaging $140.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Abbott$6K
- Boston Scientific$3K
- Biosense Webster, Inc.$1K
- Impulse Dynamics (USA) Inc.$573
- Biotronik Inc.$437
- plus $632 from 7 others
Across 17 payments — averaging $835.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$5K
- Biotronik Inc.$5K
- Medtronic$5K
What the payments were for
- Consulting fees$5,06316%
- Speaking & faculty fees$7,76125%
- Travel & lodging$7,41923%
- Food & beverage$11,39836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 62 | $19,768 |
| Abbott | 57 | $5,725 |
| Boston Scientific | 40 | $3,393 |
| Biosense Webster, Inc. | 30 | $1,115 |
| Impulse Dynamics (USA) Inc. | 17 | $573 |
| Biotronik Inc. | 10 | $437 |
| Elutia, Inc. | 2 | $281 |
| Sanofi | 1 | $160 |
| Heartflow, Inc. | 1 | $103 |
| Pfizer | 2 | $32 |
| Cardiva Medical, Inc. | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,693
- Watchman$934
- Carto 3$618
- GENERAL - THERAPIES$493
- LINQ II$493
- Micra$432
- Farapulse$423
- WATCHMAN FLX$304
- ECM Patch,Pouch$281
- OPTIMIZER$244
- Confirm Rx$242
- BioMonitor$232
- Ensite Cardiac Mapping System$173
- Rhythmia Mapping System$162
- MULTAQ$160
- Claria MRI$152
- SPHERE-9$131
- COBALT DR MRI SURESCAN$130
- Pentaray Nav$121
- VISITAG SURPOINT External Processing Unit$121
How this compares
$31,641 in reported general payments places this provider in the 65th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 579 | $772,433 |
| XareltoRivaroxaban | 224 | $252,928 |
| EntrestoSacubitril/Valsartan | 120 | $161,130 |
| Repatha SureclickEvolocumab | 53 | $37,641 |
| MultaqDronedarone Hcl | 18 | $24,674 |
| JardianceEmpagliflozin | 20 | $18,001 |
| Metoprolol Succinate | 411 | $8,053 |
| CorlanorIvabradine Hcl | 11 | $6,598 |
| Atorvastatin Calcium | 408 | $6,064 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $5,746 |
| Flecainide Acetate | 91 | $4,953 |
| Rosuvastatin Calcium | 231 | $4,764 |
| Ezetimibe | 52 | $2,089 |
| ClopidogrelClopidogrel Bisulfate | 94 | $1,931 |
| Metoprolol Tartrate | 236 | $1,904 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $32 | $772,433579 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Philadelphia
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pasquale SantangeliPhiladelphia$581K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
- Timothy MarkmanPhiladelphia$402K
- David CallansPhiladelphia$350K
- Robert SchallerPhiladelphia$333K
- Matthew HymanPhiladelphia$294K
- David FrankelPhiladelphia$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.